GlassScriptPhysician profile
Kevin J Campbell
NPI 1427437318
$17,676.67
in general payments reported to CMS, 2019-2025
16 companies · $1,726 in 2025
The $1,726 reported for 2025 was more than what 77% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $226 · 2020: $422 · 2021: $516 · 2022: $6,253 · 2023: $5,194 · 2024: $3,340 · 2025: $1,726.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,389 · Travel and Lodging: $4,435 · Consulting Fee: $400 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,389.42 |
| Travel and Lodging | $4,435.29 |
| Consulting Fee | $400.00 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $7,235.58 | 2019-2024 | Xiaflex, Aveed, Edex |
| Coloplast Corp | $6,333.55 | 2020-2025 | Titan |
| Boston Scientific Corporation | $3,038.04 | 2021-2025 | Advance Xp, Ams 700, Ams 700 Cxr Rte Kit |
| Astellas Pharma US INC | $291.73 | 2019-2023 | Xtandi |
| Antares Pharma, INC. | $150.00 | 2022-2023 | Tlando, Xyosted |
| Ambu INC. | $114.84 | 2023 | |
| Endo USA, INC. | $89.50 | 2025 | Xiaflex |
| Rigicon,INC. | $86.07 | 2023 | Rigi10 Malleable Penile Prosthesis |
| Teleflex LLC | $77.12 | 2022-2023 | Urolift |
| Acerus Pharmaceuticals Corporation | $64.23 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $49.65 | 2021 | |
| Tolmar, INC. | $44.38 | 2023 | |
| Therapeuticsmd, INC. | $35.17 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| Novo Nordisk INC | $18.90 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Clarus Therapeutics INC. | $12.85 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Campbell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.